237 related articles for article (PubMed ID: 29255346)
1. Hepatoprotective effect of calculus bovis sativus on nonalcoholic fatty liver disease in mice by inhibiting oxidative stress and apoptosis of hepatocytes.
He W; Xu Y; Zhang C; Lu J; Li J; Xiang D; Yang J; Chang M; Liu D
Drug Des Devel Ther; 2017; 11():3449-3460. PubMed ID: 29255346
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of Calculus Bovis Sativus in inhibiting hepatocyte lipid deposition based on serum pharmacology].
He WX; Zhang CL; Xiang D; Yang JY; Xu YJ; Ren XH; Liu D
Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3780-3785. PubMed ID: 31602953
[TBL] [Abstract][Full Text] [Related]
3. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
Jiang Y; Chen L; Wang H; Narisi B; Chen B
J Ethnopharmacol; 2015 Dec; 176():499-507. PubMed ID: 26571089
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of nonalcoholic fatty liver disease by swertiamarin in fructose-fed mice.
Yang Y; Li J; Wei C; He Y; Cao Y; Zhang Y; Sun W; Qiao B; He J
Phytomedicine; 2019 Jun; 59():152782. PubMed ID: 31005808
[TBL] [Abstract][Full Text] [Related]
5. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro.
Murakami S; Ono A; Kawasaki A; Takenaga T; Ito T
Amino Acids; 2018 Sep; 50(9):1279-1288. PubMed ID: 29946793
[TBL] [Abstract][Full Text] [Related]
6. Black Sesame Seeds Ethanol Extract Ameliorates Hepatic Lipid Accumulation, Oxidative Stress, and Insulin Resistance in Fructose-Induced Nonalcoholic Fatty Liver Disease.
Yang Y; Wang J; Zhang Y; Li J; Sun W
J Agric Food Chem; 2018 Oct; 66(40):10458-10469. PubMed ID: 30244573
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
[TBL] [Abstract][Full Text] [Related]
8. Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study.
Cheng F; Ma C; Wang X; Zhai C; Wang G; Xu X; Mu J; Li C; Wang Z; Zhang X; Yue W; Du X; Lian Y; Zhu W; Yin X; Wei Z; Song W; Wang Q
BMC Complement Altern Med; 2017 Apr; 17(1):203. PubMed ID: 28388904
[TBL] [Abstract][Full Text] [Related]
9. Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
Takahara I; Akazawa Y; Tabuchi M; Matsuda K; Miyaaki H; Kido Y; Kanda Y; Taura N; Ohnita K; Takeshima F; Sakai Y; Eguchi S; Nakashima M; Nakao K
PLoS One; 2017; 12(3):e0170591. PubMed ID: 28278289
[TBL] [Abstract][Full Text] [Related]
10. Diet high in fructose promotes liver steatosis and hepatocyte apoptosis in C57BL/6J female mice: Role of disturbed lipid homeostasis and increased oxidative stress.
Choi Y; Abdelmegeed MA; Song BJ
Food Chem Toxicol; 2017 May; 103():111-121. PubMed ID: 28257781
[TBL] [Abstract][Full Text] [Related]
11. A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets.
Hong M; Li S; Wang N; Tan HY; Cheung F; Feng Y
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335383
[No Abstract] [Full Text] [Related]
12. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.
Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH
Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529
[TBL] [Abstract][Full Text] [Related]
13. Hepatoprotective Effects of Soybean Embryo by Enhancing Adiponectin-Mediated AMP-Activated Protein Kinase α Pathway in High-Fat and High-Cholesterol Diet-Induced Nonalcoholic Fatty Liver Disease.
Hong J; Kim S; Kim HS
J Med Food; 2016 Jun; 19(6):549-59. PubMed ID: 27266339
[TBL] [Abstract][Full Text] [Related]
14. Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice.
Bagci R; Sahinturk V; Sahin E
Tissue Cell; 2019 Aug; 59():62-69. PubMed ID: 31383290
[TBL] [Abstract][Full Text] [Related]
15. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
[TBL] [Abstract][Full Text] [Related]
16. Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats.
Mengesha T; Gnanasekaran N; Mehare T
BMC Complement Med Ther; 2021 Mar; 21(1):104. PubMed ID: 33785007
[TBL] [Abstract][Full Text] [Related]
17. Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries.
Liu Q; Pan R; Ding L; Zhang F; Hu L; Ding B; Zhu L; Xia Y; Dou X
Int Immunopharmacol; 2017 Aug; 49():132-141. PubMed ID: 28577437
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of Kangxian ruangan capsule against nonalcoholic fatty liver disease fibrosis in rats induced by MCD diet.
Liu L; Zhou Y; Dai D; Xia H; Zhao K; Zhang J
Biomed Pharmacother; 2018 Dec; 108():424-434. PubMed ID: 30236852
[TBL] [Abstract][Full Text] [Related]
19. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.
Shan W; Gao L; Zeng W; Hu Y; Wang G; Li M; Zhou J; Ma X; Tian X; Yao J
Cell Death Dis; 2015 Jul; 6(7):e1833. PubMed ID: 26203862
[TBL] [Abstract][Full Text] [Related]
20. Artemisia capillaris formula inhibits hepatic steatosis via an miR‑122‑induced decrease in fatty acid synthase expression in vivo and in vitro.
Liu L; Zhao J; Li Y; Wan Y; Lin J; Shen A; Xu W; Li H; Zhang Y; Xu J; Peng J; Hong Z
Mol Med Rep; 2016 Jun; 13(6):4751-8. PubMed ID: 27081834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
